The role of major histocompatibility complex (MHC) class I-and class II-restricted functions in Helicobacter pylori infection and immunity upon oral immunization was examined in vivo. Experimental challenge with H. pylori SS1 resulted in significantly greater (P < 0.025) colonization of MHC class I and class II mutant mice than C57BL/6 wild-type mice. Oral immunization with H. pylori whole-cell lysates and cholera toxin adjuvant significantly reduced the magnitude of H. pylori infection in C57BL/6 wild-type (P ‫؍‬ 0.0083) and MHC class I knockout mice (P ‫؍‬ 0.0048), but it had no effect on the H. pylori infection level in MHC class II-deficient mice. Analysis of the anti-H. pylori antibody levels in serum showed a dominant serum immunoglobulin G1 (IgG1 
Helicobacter pylori is a gram-negative bacterium with gastric trophism that is implicated in the development of chronic gastritis, peptic ulceration, gastric adenocarcinoma, and lymphoma (4, 23, 25) . Infection with Helicobacter spp. results in the development of markedly heterogeneous systemic immunoglobulin G (IgG) and mucosal IgA antibody responses (6, 26) . Whereas populations of B cells can assemble into gastric lymphoid follicles and germinal centers driven by persistent antigenic stimulation (14, 30) , the antibody and lymphofollicular reactions generated during Helicobacter infections are insufficient for clearance. On the other hand, populations of CD3 ϩ , CD4 ϩ CD8 Ϫ , and CD4 Ϫ CD8 ϩ T cells (2, 14) are recruited into gastric tissue during Helicobacter infections. A high frequency of H. pylori CD4 ϩ T-cell clones derived from infected gastric biopsies respond to H. pylori antigenic stimulation in vitro in a Th1-like fashion (9, 10) . At present, the relative contributions of gastric IgA-committed B cells and of Helicobacter-specific T cells in H. pylori immunity are not understood, although recent studies in murine models of Helicobacter felis infection have shown that Th2-type cells may reduce the infection level (21) .
The experiments presented here examined the H. pylori infection density and the ability of oral immunization to interfere with H. pylori infection in major histocompatibility complex (MHC) class I or class II mutant mice. We show the role of CD4 ϩ and CD8 ϩ T cells in the regulation of H. pylori infection level and the requirement for CD4 ϩ CD8 Ϫ T cells for effective immunity against H. pylori infection.
MATERIALS AND METHODS
H. pylori infection and immunization schedules. Groups (n ϭ 10) of 6-to
, and C57BL/6 wild-type mice were obtained from Taconic Farms (Germantown, N.Y.) and maintained in laminar flow microisolators for the duration of the experimental treatments. The mice were immunized per os (0.25 ml) with a blunt feeding needle (Popper & Sons, Inc., New Hyde Park, N.Y.) four times weekly with 500 g of H. pylori whole-cell lysate antigens and 10 g of cholera toxin (CT) adjuvant (Calbiochem, La Jolla, Calif.) in 0.2 M bicarbonate buffer (pH 8.0), with buffer and 10 g of CT adjuvant or with buffer alone, and challenged 2 weeks later with 10 6 CFU of H. pylori SS1 (19; kindly provided by A. Lee, University of New South Wales). Previous studies demonstrated that this H. pylori challenge doses resulted in 100% infection rates and represented Ͼ100 50% infective doses in C57BL/6 mice. The experiment was terminated 2 weeks after H. pylori challenge.
Growth of H. pylori and experimental challenge. H. pylori SS1 was grown on tryptic soy agar (TSA) plates (Becton Dickinson, Cockeysville, Md.) containing 5% sheep blood (Remel, Lenexa, Kans.) and 100 g of vancomycin, 3.3 g of polymyxin B, 200 g of bacitracin, 10.7 g of nalidixic acid, and 50 g of amphotericin B (Sigma Chemical Co., St. Louis, Mo.) per ml. The plates were incubated for 72 to 80 h at 37°C in 10% CO 2 and 5% O 2 in a Trigas incubator (Queue Systems, Asheville, N.C.). The bacteria were then harvested, inoculated into brucella broth (BBL; Becton Dickinson) supplemented with 5% fetal bovine serum (Intergen, Purchase, N.Y.), and shaken at 120 rpm at 37°C in the Trigas incubator. Cultures were grown to an optical density at 600 nm (OD 600 ) of 0.3 (ca. 5 ϫ 10 8 CFU/ml) and diluted in brucella broth for inoculation. Prior to use, H. pylori cells were analyzed in wet mounts to assess motility and morphology and subjected to urease, catalase and oxidase tests.
Preparation of H. pylori antigens. H. pylori was grown on selective blood agar plates at 37°C in 10% CO 2 and suspended in 20 mM phosphate-buffered saline (PBS; pH 7.5). The cells were washed three times in PBS by centrifugation (12,000 ϫ g) for 20 min at 4°C and disrupted by passage through a French press at a pressure of 15,000 lb/in 2 . After centrifugation (2,000 ϫ g for 10 min) to remove cell fragments, the protein content was determined by the Bio-Rad protein assay, and aliquots were frozen at Ϫ70°C until used.
Assessment of H. pylori infection. Longitudinal segments of gastric tissue were homogenized in 0.5 ml of brucella broth, and replicate serial 10-fold dilutions were plated on Helicobacter-selective blood agar plates. The plates were incubated (37°C in a Trigas incubator), and quantitation of the CFU was performed 5 to 7 days later. For determination of infection with a urease assay, segments of antrum, including the corpus-antrum junction, were incubated in urea broth as described elsewhere (15) . After 4 h, the extent of color change was recorded in an automated enzyme-linked immunosorbent assay (ELISA) reader at OD 550 .
Determination of serum and gastric anti-H. pylori antibody levels. Blood was obtained from the retroorbital sinus at the termination of the experiment. Gastric secretions were collected with absorbent wicks (15) positioned longitudinally in the gastric lumen after the stomach was rinsed extensively with PBS containing 0.2 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride (Calbiochem), 1 g of aprotinin per ml, 10 M leupeptin (Sigma), and 3.25 M Bestatin (Boehringer Mannheim Biochemicals, Indianapolis, Ind.) protease inhibitors (17) . An ELISA was used for antibody measurements (24) . In brief, triplicate wells of microtiter plates (Dynatech, Chantilly, Va.) were incubated with purified H. pylori SS1 lysate antigens (100 g/ml) in carbonate buffer. After being washed with PBS-0.5% Tween 20, the wells were blocked with PBS-Tween containing 2.5% nonfat dry milk and incubated for 1 h at 37°C with serial dilutions of sera or gastric secretions. The wells were then incubated with biotinylated goat anti-mouse IgG1, anti-mouse IgG2a, or anti-mouse IgA (Southern Biotechnology, Birmingham, Ala.), followed by streptavidin-alkaline phosphatase (Calbiochem). Negative control sera and positive serum controls with known anti-H. pylori activity were included in each assay.
Immunohistochemical analyses of gastric resident leukocytes. Longitudinal sections of gastric tissue, from the esophageal junction to the pyloric antrum, were mounted in OCT compound (Miles Scientific, Naperville, Ill.) and frozen in liquid nitrogen as described elsewhere (24) . Tissue sections (7 m) were fixed with acetone, and biotin-avidin binding sites were blocked for 30 min (Vector Laboratories, Burlingame, Calif.). The tissue sections were incubated with the biotinylated monoclonal antibodies (MAb) anti-CD4 (GK1.5), anti-CD8␣ (53-6.7), anti-CD49d (9C10), anti-CD54 (3E2), anti-H-2K b and -H-2D b MHC class I (28-8-6), or anti-I-A b MHC class II (KH74) (Pharmingen, San Diego, Calif.), followed by avidin conjugated to biotinylated horseradish peroxidase (ABC; Vector Laboratories) as described elsewhere (24) . Cell-bound peroxidase was visualized with 0.05% diaminobenzidine tetrahydrochloride (Organon Teknika, Durham, N.C.) and 0.01% H 2 O 2 in PBS. For identification of IgA-containing cells (IgACC), the tissue sections were incubated with biotinylated goat antimouse IgA (Southern Biotechnology), followed by avidin conjugated to biotinylated glucose oxidase (ABC-GO; Vector Laboratories). Cell-bound GO was visualized with TNBT tetrazolium salt (Vector Laboratories) in Tris-HCl buffer. The sections were counterstained with methyl green, and infiltrating leukocytes in the gastric antrum were quantitated in five random fields of duplicate tissue sections from each group of mice. The field was calibrated with a micrometer grid, and the mean number of cells was enumerated per field and adjusted to cells per square millimeter of tissue.
RESULTS

H. pylori infection in MHC class I and class II mutant mice.
The contribution of MHC class I or class II functions to experimental infection with H. pylori was examined. Challenge of MHC knockout mice and of C57BL/6 wild-type mice with H. pylori resulted in 90 to 100% infection rates (Table 1) . Evaluation of the magnitude of colonization by quantitative bacterial culture showed a significantly increased H. pylori burden in MHC class I (P ϭ 0.017) and MHC class II (P ϭ 0.025) mutant mice compared to that in C57BL/6 wild-type mice (Table 1) .
Protective immunity in MHC mutant mice with H. pylori antigens. The ability of oral immunization to limit the severity of H. pylori infection was investigated. Whereas oral immunization with H. pylori lysate antigens resulted in a significant reduction of the H. pylori infection level in C57BL/6 wild-type (P ϭ 0.0083) and in MHC class I-deficient (P ϭ 0.0048) mice relative to those immunized with CT alone, immunization of MHC class II mutant mice with H. pylori lysate antigens had no effect on the magnitude of H. pylori infection (Fig. 1) . Oral immunization of wild-type and MHC-deficient mice with CT did not affect the H. pylori density relative to treatment of the corresponding strain with buffer alone (not shown).
Immune response in MHC knockout and C57BL/6 control mice. Oral immunization with H. pylori cell lysate antigens resulted in the development of a serum IgG anti-H. pylori antibody response of greater magnitude in C57BL/6 wild-type mice than in MHC class I mutant mice (Fig. 2) . A higher level of serum IgG1 than IgG2a anti-H. pylori was consistently elicited as a function of oral immunization of wild-type and MHC class I mutant mice, but MHC class I knockout mice exhibited a depressed serum IgG1 and IgG2a response compared to C57BL/6 wild-type mice. In contrast, gastric H. pylori-specific IgA antibody levels were greatest in MHC class I mutant mice (Fig. 2) Phenotypic composition of gastric resident leukocytes in immunized MHC mutant mice. The distribution of mononuclear leukocytes infiltrating gastric tissue in C57BL/6, MHC class I-deficient, and MHC class II knockout mice was investigated by immunohistochemistry. Populations of T-cell-receptor (TCR) ␣␤ ϩ CD4 ϩ cells were the dominant T cells resident in the antral mucosa of C57BL/6 wild-type and MHC class I knockout mice (Table 2 ). In contrast, a high frequency of TCR␣␤ ϩ CD4 Ϫ CD8␣ ϩ cells were observed scattered in the antral mucosa and epithelia of MHC class II mutant mice (Table 2) . While approximately 10 to 20% of the gastric leukocytes expressed the ␣4 integrin subunit, the majority of infiltrating leukocytes in wild-type and MHC mutant mice exhibited the CD54 activation marker ( Table 2) 
DISCUSSION
Infection with Helicobacter spp. results in the recruitment of CD4 ϩ and CD8 ϩ T cells in gastric tissue (2, 14) . The accumulation of gastric Th1-type H. pylori-specific CD4 ϩ cells has been proposed to account for their failure to generate protective immunity and to contribute to disease pathogenesis (2, 9). Although peripheral T cells derived from infected mice are unable to mediate clearance when adoptively transferred into H. felis-infected recipients (21) ϩ T cells activated after mucosal immunization may be involved in protective immunity against H. pylori in vivo. Although the events in T-cell activation, recirculation, and cytokine secretion are not understood, a low incidence of ␣4 ϩ T cells was observed in gastric tissue of immunized wild-type and MHC knockout mice. The ␣4 integrin can be coexpressed either with the ␤1 subunit to form VLA-4, which mediates leukocyte transendothelial migration (28), or with the ␤7 integrin subunit to direct lymphocyte homing via the mucosal vascular addressin MAdCAM (3). The small numbers of ␣4 ϩ TCR␣␤ ϩ cells suggested that T-cell populations recruited into gastric tissue after immunization may be largely derived from peripheral lymphoid organs, rather than recirculating from Peyer's patches or the intestinal lamina propria. Previous studies have suggested that mucosal IgA (8, 24) or IgG (13) antibody may mediate immunization-induced protection from Helicobacter infections, and this might explain the absence of effective immunity in MHC class II-deficient mice reported here. However, the relationship between antibody level and the extent of host protection against Helicobacter infections is discordant (20) , and oral immunization may confer protection from H. felis infection in B-cell-deficient MT mice (22) . Furthermore, while MHC class I mutant mice show a less-efficient serum antibody response than do wild-type mice (28) and, as shown in this study, also exhibit depressed serum anti-H. pylori IgG responses after oral immunization, the extent of protective efficacy against H. pylori was comparable to that observed in wild-type mice. The finding that orally immunized MHC class II mutant mice generated a frequency of gastric IgACC equivalent to that of wild-type and MHC class I mutant mice is consistent with observations that CD4-deficient mice fail to respond to oral antigenic stimulation despite having a normal complement of mucosal IgA B cells (18) . Thus, while orally immunized wild-type and MHC knockout mice harbored equivalent frequencies of IgACC, the magnitude of serum or gastric antibody responses was not predictive of the extent of protective immunity.
A common histopathologic feature in H. felis-immunized mice is the progressive infiltration into gastric tissue of CD4 ϩ and, to a greater extent, CD8
ϩ T-cell populations of unknown function (12) . The observations reported here that gastric tissue of MHC class II knockout mice contained a high incidence of CD4 Ϫ CD8 ϩ CD54 ϩ activated T cells within 2 weeks of H. pylori challenge may help to define the functional contribution of CD8 ϩ cells to gastritis and epithelial-cell damage in the absence of CD4 ϩ T cells. While gastric leukocyte infiltration appears to be a hallmark of protective anti-Helicobacter immunity in murine models, the H. pylori infection density in humans has been found to be associated with the degree of gastritis (1), and patients infected with the human immunodeficiency virus (HIV) show a lower incidence of gastritis and a lower prevalence of H. pylori infection relative to HIV-negative subjects (5, 11) . Because T-cell recruitment into murine gastric tissue may be mediated by residual antigenic stimulation by live Helicobacter organisms in previously immunized hosts (12) and because CD4 ϩ cells can regulate mucosal inflammatory reactions (27) , the findings reported here raise the possibility that CD4 ϩ T-cell populations generated during immunization in vivo may play an important role in limiting the severity of an H. pylori infection. Currently, it is not clear whether the lack of immune protection identified in MHC class II knockout mice is related to a deficit of CD4 ϩ T cells in peripheral and gastric tissues or whether it is associated with elimination of class II MHCrestricted antigen presentation by gastric epithelia. However, both the current findings and the observation that T cells can reduce the H. felis burden when adoptively transferred into unimmunized recipients (21) strongly implicate CD4 ϩ T cells in the protection against H. pylori infection.
